Objectives : We hypothesized that early recurrent myocardial infarction (MI) following
fibrinolytic administration would be assessed with higher mortality at both 30 days and 2 years. …

Background Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic
stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral …

Objectives : We examined the safety and efficacy of nonculprit multivessel compared with
culprit-only stenting in patients with multivessel disease presenting with unstable angina or non…

Objective Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) can result in high
residual gradients that are associated with increased mortality. Bioprosthetic valve fracture …

Impaired coronary artery blood flow and left anterior descending (LAD) artery culprit
location are angiographic variables that have been associated with poorer outcomes after …

Background: The problem of drug-eluting stents increasing the risk for late thrombosis,
especially when antiplatelet therapy becomes interupted, is a growing concern (1). Recently, a …

The use of intravenous thrombolytic agents has revolutionised the treatment of acute myocardial
infarction. However, the improved mortality achieved with these drugs is tempered by …

BACKGROUND: Aspirin inhibits platelet aggregation and is widely used in the treatment of
cardiovascular disease. Some individuals are less responsive to aspirin's antiplatelet effect, a …

Background: Shorter distances from the coronary ostia to culprit lesions have been associated
with a higher incidence of adverse outcomes in ST elevation acute myocardial infarction (…

Left main (LM) coronary disease, carotid artery disease, and peripheral arterial disease each
reflects advanced atherosclerosis. The frequency of their coexistence in the same patient …